Archives

30 October 2020 ASX ANNOUNCEMENT MVP and MundiPharma agree to cease distribution and licensing agreement in Australia MVP today announced it has taken back the distribution rights for its pain relief drug Penthrox in the Australian market from MundiPharma. Since assigning the rights to Mundipharma a year ago, the global Mundipharma organisation has gone through […]

28 October 2020 ASX ANNOUNCEMENT Chairman’s and CEO’s Address to Shareholders Medical Developments International Limited today held its 2020 Annual General Meeting.  The AGM Chairman and CEO address to shareholders is contained in the following link – ASX Announcement – Chairman’s and CEO’s Address to Shareholders

14 October 2020 ASX ANNOUNCEMENT Appointment of Chief Executive Officer – Brent MacGregor Medical Developments International Limited (ASX: MVP) is delighted to announce the appointment of Brent MacGregor as Chief Executive Officer of the Company from 1 November 2020.  The key terms of his employment are an attachment to this announcement. Refer to the following […]

19 August 2020 ASX ANNOUNCEMENT Head of Europe Appointed Medical Developments International (ASX: MVP) is pleased to announce the appointment of Mr Stefaan Schatteman as Head of its European business effective immediately. Stefaan will lead the Company’s direct push into the 27 member states in the EU and Switzerland. Stefaan is a 15-year veteran of […]

19 August 2020 ASX ANNOUNCEMENT Medical Developments to take control of EU markets Medical Developments International (ASX: MVP) today announced it has reached in principle agreement to enter into a contract with the Mundipharma network in Europe to take back the distribution rights for its pain relief drug, Penthrox® in all 27 member states in […]

26 May 2020 ASX ANNOUNCEMENT Appointment of Non-Executive Director – Christine Emmanuel Medical Developments International Limited (ASX: MVP) is pleased to announce the appointment of Christine Emmanuel as a Non-Executive Director of the Company with immediate effect. Christine has a Bachelor of Science and major in Economics (Hons: Chem) from Monash University, Certificate in Intellectual […]

25 May 2020 ASX Announcement Penthrox approved in Hungary Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in Hungary.  The Marketing Authorisation issued by the National Institute of Pharmacy and Nutrition (OGYÉI), is for Penthrox® to be used for emergency relief of moderate to severe pain in […]

5 May 2020 ASX Announcement Penthrox approved in The Netherlands and Bosnia & Herzegovina. Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in The Netherlands and Bosnia & Herzegovina.  The Marketing Authorisation issued by the Medicines Evaluation Board of the Netherlands and the Agency for Medicinal […]

28 April 2020 ASX Announcement Penthrox is approved in Thailand Medical Developments International Limited (ASX: MVP), announce today that Penthrox® has been granted Market Authorisation in the Kingdom of Thailand. The Marketing Authorisation issued by the Thailand Food and Drug Administration (TFDA), is for Penthrox® to be used for Emergency relief of moderate to severe […]

19 February 2020 ASX ANNOUNCEMENT MVP has today released its FY20 Half Year Report and Accounts. Please refer to the following link for a copy – MVP FY20 Half Year Report